U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7491174911Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin AnaloguesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Other: No treatment given|Other: No treatment givenhttps://ClinicalTrials.gov/show/NCT01585506
7491274912CHANGE -it is About LifeActive, not recruitingNo Results AvailableSchizophrenia|Metabolic SyndromeOther: Treatment as usual|Behavioral: Care coordinator|Behavioral: CHANGEhttps://ClinicalTrials.gov/show/NCT01585493
7491374913Preventing Obesity in the Worksite: A Multi-Message, Multi-"Step" ApproachCompletedNo Results AvailableObesityBehavioral: Weight Gain Prevention Interventionhttps://ClinicalTrials.gov/show/NCT01585480
7491474914Anterior Shoulder DislocationCompletedNo Results AvailableShoulder Dislocationhttps://ClinicalTrials.gov/show/NCT01585467
7491574915Healthy Lifestyle in PregnancyNot yet recruitingNo Results AvailableHperglycemia|Diabetes Mellitus|Weight Gainhttps://ClinicalTrials.gov/show/NCT01585454
7491674916Finasteride for Chronic Central Serous ChorioretinopathyTerminatedHas ResultsRetinal DiseaseDrug: Finasteride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01585441
7491774917Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated CancersRecruitingNo Results AvailableCervical Cancer|Oropharyngeal Cancer|Vaginal Cancer|Anal Cancer|Penile CancerDrug: Fludarabine|Drug: Cycolphosphamide|Biological: Young TIL|Drug: Aldesleukinhttps://ClinicalTrials.gov/show/NCT01585428
7491874918Vemurafenib and White Blood Cell Therapy for Advanced MelanomaActive, not recruitingNo Results AvailableMetastatic Cancer|MelanomaDrug: Vemurafenib|Drug: Young TIL|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Aldesleukinhttps://ClinicalTrials.gov/show/NCT01585415
7491974919Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC)RecruitingNo Results AvailableArterial Calcification Due to CD73-Deficiency (ACDC)Drug: Etidronate|Procedure: MRI|Procedure: CT Scan|Procedure: ABI|Procedure: Treadmill|Procedure: Dexa Scan|Procedure: Hand X-rayhttps://ClinicalTrials.gov/show/NCT01585402
7492074920Studying Gene Expression and Location in Samples From Patients With Brain TumorsActive, not recruitingNo Results AvailableBrain and Central Nervous System TumorsGenetic: gene expression analysis|Genetic: genetic linkage analysis|Genetic: microarray analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01585389
7492174921Studying Genes in Samples From Younger Patients With RhabdomyosarcomaActive, not recruitingNo Results AvailableSarcomaGenetic: mutation analysis|Genetic: nucleic acid sequencing|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01585376
7492274922A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma PatientsActive, not recruitingNo Results AvailableMelanomaBiological: MELITAC 12.1 + Montanide ISA-51 + lipopolysaccharide (LPS)|Biological: MELITAC 12.1 + Montanide ISA-51 + polyICLChttps://ClinicalTrials.gov/show/NCT01585350
7492374923Trunk Forward Ability in Patients With Lumbar FusionRecruitingNo Results AvailableFusion of Spine, Lumbar Regionhttps://ClinicalTrials.gov/show/NCT01585337
7492474924A Study of The Relationship Between Drop in Hemoglobin and Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a)CompletedHas ResultsHepatitis C, ChronicDrug: peginterferon alfa-2a [Pegasys]|Drug: ribavirin [Copegus]https://ClinicalTrials.gov/show/NCT01585324
7492574925Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)Enrolling by invitationNo Results AvailableSubarachnoid Hemorrhage (SAH)|Tachycardiahttps://ClinicalTrials.gov/show/NCT01585311
7492674926STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)RecruitingNo Results AvailableMultiple SclerosisDrug: FTY720https://ClinicalTrials.gov/show/NCT01585298
7492774927Coronary Artery Bypass Grafting Strategies for the Anterolateral Territory: a Prospective Randomized Clinical TrialRecruitingNo Results AvailableCoronary Artery DiseaseProcedure: LIMA to SVG Bridge Technique|Procedure: Conventional CABGhttps://ClinicalTrials.gov/show/NCT01585285
7492874928Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's DementiaActive, not recruitingNo Results AvailableAlzheimer's DementiaDrug: ENA713https://ClinicalTrials.gov/show/NCT01585272
7492974929Anfibatide Phase Ib-IIa Clinical TrialActive, not recruitingNo Results AvailableNon-ST Segment Elevation Myocardial InfarctionDrug: Anfibatide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01585259
7493074930Saw Palmetto: Symptom Management for Men During Radiation TherapyActive, not recruitingNo Results AvailableProstate CancerDrug: Saw Palmettohttps://ClinicalTrials.gov/show/NCT01585246
7493174931A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNo Results AvailablePsoriasisDrug: ASKP1240|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01585233
7493274932Efficacy and Safety Study of Neuramis in Correction of Nasolabial FoldRecruitingNo Results AvailableNasolabial FoldDevice: HA fillerhttps://ClinicalTrials.gov/show/NCT01585220
7493374933Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's DisorderCompletedNo Results AvailableTourette's DisorderDrug: vigabatrinhttps://ClinicalTrials.gov/show/NCT01585207
7493474934Phase II Study of Nivolumab in Combination With Ipilimumab for Uveal MelanomaRecruitingNo Results AvailableMelanoma|Uveal MelanomaDrug: Nivolumab|Drug: Ipilimumabhttps://ClinicalTrials.gov/show/NCT01585194
7493574935Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200CompletedNo Results AvailableCholeraBiological: PXVX0200|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01585181
7493674936Functional Neuroimaging of Alcoholism Vulnerability (PIT)RecruitingNo Results AvailableHealthyDrug: Memantine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01585168
7493774937Clinical Study of TA-650 in Pediatric Patients With Ulcerative ColitisCompletedNo Results AvailablePediatric Ulcerative ColitisDrug: TA-650https://ClinicalTrials.gov/show/NCT01585155
7493874938Growth of Infants Fed With BabyNes SystemCompletedNo Results AvailableDietary ModificationOther: Test formulahttps://ClinicalTrials.gov/show/NCT01585142
7493974939Treatment Utility of Postpartum Antibiotics in ChorioamnionitisTerminatedNo Results AvailableThe Primary Outcome of This Study Will be the Rate of Endometritis in the Study Population.Drug: Postpartum Antibiotics|Drug: No postpartum antibioticshttps://ClinicalTrials.gov/show/NCT01585129
7494074940Cytosponge Protocol IRB 11-006429RecruitingNo Results AvailableEosinophilic EsophagitisDevice: Cytosponge - Brushinghttps://ClinicalTrials.gov/show/NCT01585103

* Görseller ve İçerik tekif hakkına sahip olabilir